Recent evidence shows that lncRNA ZEB2-AS1 (also known as ZEB2AS, ZEB2-AS, ZEB2NAT) modulates the invasion and EMT progression in bladder cancer as well as in gastric cancer [99,100]. This evidence concerns the gene ZEB2-AS1 and gastric cancer.